Non-interventional Cross-over Study to Reduce Items of PROactive Tools Measuring Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)
NCT ID: NCT01388218
Last Updated: 2018-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
236 participants
OBSERVATIONAL
2011-07-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity Versus Pulmonary Rehabilitation in COPD
NCT02161393
Study to Evaluate the Impact of the "PROactive Telecoaching Program" on Physical Activity in Patients With COPD.
NCT01992081
Impact of "Telecoaching Program" on Physical Activity in Patients With COPD
NCT02158065
Personalised Exercise Training in COPD
NCT03817294
Developing Personalised Relative Physical Activity Thresholds in COPD.
NCT06330623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1 - Daily+Clinical
Order of assessment: Daily PRO + Clinical visit PRO
No interventions assigned to this group
Arm 2 - Clinical+Daily
Order of assessment: Clinical visit PRO + Daily PRO
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current or ex-smokers with a smoking history equivalent to at least 10 pack years.
* Able to read and write and to use electronic devices and physical activity monitor.
Exclusion Criteria
* Respiratory diseases other than COPD (e.g. asthma).
* Cognitive impairment, as judged by the investigator
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
University of Edinburgh
OTHER
Royal Brompton & Harefield NHS Foundation Trust
OTHER
University Medical Center Groningen
OTHER
University of Athens
OTHER
Barcelona Institute for Global Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Judith Garcia-Aymerich, MD, PhD
Role: STUDY_CHAIR
Barcelona Institute for Global Health
Niklas Karlsson
Role: STUDY_CHAIR
AstraZeneca
Thierry Troosters
Role: PRINCIPAL_INVESTIGATOR
KUL Leuven
Thys van der Molen
Role: PRINCIPAL_INVESTIGATOR
University Medical Center Groningen
Nick Hopkinson, MD
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Roberto Rabinovich, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Edinburgh
Ioannis Vogiatzis, PhD
Role: PRINCIPAL_INVESTIGATOR
Thorax Research Foundation Athens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Gasthuisberg, Katholieke Universiteit Leuven
Leuven, , Belgium
Thorax Research Foundation
Athens, , Greece
University Medical Center
Groningen, , Netherlands
Royal Brompton Hospital, Imperial College
London, England, United Kingdom
ELEGI/Colt laboratory UoE/MRC Centre for Inflammation Research The Queen's Medical Research Institute, University of Edinburgh
Edinburgh, Scotland, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gimeno-Santos E, Raste Y, Demeyer H, Louvaris Z, de Jong C, Rabinovich RA, Hopkinson NS, Polkey MI, Vogiatzis I, Tabberer M, Dobbels F, Ivanoff N, de Boer WI, van der Molen T, Kulich K, Serra I, Basagana X, Troosters T, Puhan MA, Karlsson N, Garcia-Aymerich J; PROactive consortium. The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease. Eur Respir J. 2015 Oct;46(4):988-1000. doi: 10.1183/09031936.00183014. Epub 2015 May 28.
Demeyer H, Gimeno-Santos E, Rabinovich RA, Hornikx M, Louvaris Z, de Boer WI, Karlsson N, de Jong C, Van der Molen T, Vogiatzis I, Janssens W, Garcia-Aymerich J, Troosters T, Polkey MI; PROactive consortium. Physical Activity Characteristics across GOLD Quadrants Depend on the Questionnaire Used. PLoS One. 2016 Mar 14;11(3):e0151255. doi: 10.1371/journal.pone.0151255. eCollection 2016.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROactive WP4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.